Author: Webdesk

Don't miss daily news

Public corruption bane of national dev’t – EFCC

Mr Ola Olukoyede, the Chairman of the Economic and Financial Crimes Commission (EFCC), has described public corruption as the major impediment to sustainable development in Nigeria.

Olukoyede said this in Abuja during a courtesy visit by Mohammed She…

Read More

UN chief urges leaders of regional bloc to end wars

UN Secretary-General António Guterres said that deep global divisions and conflicts must end to clear a path to tackling the world’s two existential threats – climate change and the negative impacts of artificial intelligence.

Guterres said this in h…

Read More

Nigeria gets nod to host African Energy Bank

Nigeria has been granted the hosting right for the African Energy Bank (AEB), after beating Ghana, Benin Republic, Algeria, South Africa and Cote D’Ivoire in a keenly contested bidding.

Sen. Heineken Lokpobiri, the Minister of State, Petroleum Resour…

Read More

Security agencies apprehend 2,678 suspects in June

The Strategic Communication Interagency Policy Committee (SCIPC), says the law enforcement agencies have apprehended 2,678 suspects for various offences across the country in June.

SCIPC is a committee of the spokespersons for the military, police, i…

Read More

FG mulls indigenous blockchain technology dev’t

The Federal Government has announced plans to develop a home grown blockchain technology to ensure protection of the national database for enhance security.

Malam Kashifu Inuwa, Director-General, National Information Technology Development Agency (NI…

Read More

Nearly 5 000 on Ongwediva housing waiting list

Ongwediva Town Council Chief Executive Officer, Damian Egumbo has revealed that there are 4 901 people on the town’s housing waiting list.

Egumbo in an interview with Nampa on Thursday said 3 040 of the applicants are from the low income earner categ…

Read More

CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe

MARBURG, Germany, July 04, 2024 (GLOBE NEWSWIRE) — Global biotechnology leader CSL Behring (ASX: CSL) today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the first gene therapy administered as a treatment in a real-world setting for hemophilia B in Europe. […]

Read More